Mark Conley
Director of Finance/CFO chez RADIUS HEALTH, INC.
Profil
Mark Conley is currently the Chief Financial Officer, Treasurer, CAO & VP at Radius Health, Inc. He previously worked as the Director-Global Finance at Thermo Fisher Scientific, Operations Controller at Haemonetics Corp., Vice President-Financial Planning & Analysis at Iron Mountain, Treasurer, Vice President & Controller at Valeritas Holdings, and Chief Financial Officer & Controller at HoltraChem, Inc. He also worked as the Vice President-Finance at Kaleido Biosciences, Inc. Mr. Conley received his undergraduate degree from Oklahoma State University in 1983 and his MBA from Bryant University in 1999.
Postes actifs de Mark Conley
| Sociétés | Poste | Début |
|---|---|---|
| RADIUS HEALTH, INC. | Director of Finance/CFO | 15/03/2022 |
Anciens postes connus de Mark Conley
| Sociétés | Poste | Fin |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01/03/2022 |
| VALERITAS HOLDINGS, INC. | Comptroller/Controller/Auditor | 13/01/2020 |
| THERMO FISHER SCIENTIFIC | Director of Finance/CFO | 01/01/2012 |
| IRON MOUNTAIN INCORPORATED | Comptroller/Controller/Auditor | 01/01/2004 |
HoltraChem, Inc.
 HoltraChem, Inc. Wholesale DistributorsDistribution Services Part of Pressure Vessel Service, Inc., HoltraChem, Inc. distributes alkalies and chlorine chemicals. The private company is based in Natick, MA. HoltraChem was acquired by Pressure Vessel Service, Inc. on October 29, 1998. | Director of Finance/CFO | 01/01/1998 |
Formation de Mark Conley
| Oklahoma State University | Undergraduate Degree |
| Bryant University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| IRON MOUNTAIN INCORPORATED | Finance |
| THERMO FISHER SCIENTIFIC | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Valeritas Holdings, Inc. develops and commercializes insulin delivery devices. The company was founded by Leisa Swanson and Robert R. Gonnelli on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
HoltraChem, Inc.
HoltraChem, Inc. Wholesale DistributorsDistribution Services Part of Pressure Vessel Service, Inc., HoltraChem, Inc. distributes alkalies and chlorine chemicals. The private company is based in Natick, MA. HoltraChem was acquired by Pressure Vessel Service, Inc. on October 29, 1998. | Distribution Services |
